Funder: American Brain Tumor Association
Due Dates (Anticipated): December 2026 (LOI) | March 2027 (Full application)
Funding Amounts: Up to $50,000 in direct costs for one year
Summary: Seed funding for early-career faculty pursuing high-risk, high-impact brain tumor research that could change diagnosis or treatment.
Key Information: A mandatory LOI precedes invitation-only full applications; applicants must hold a full-time faculty or institution-confirmed equivalent position.
Description
The American Brain Tumor Association’s Discovery Grants support early-stage ideas with the potential to change diagnostic or treatment paradigms for adult and pediatric brain tumor care. The program provides seed funding for novel approaches and the preliminary studies investigators need to pursue larger grants. Scientists outside traditional biological fields are encouraged to apply.
Projects may address any brain tumor type: benign or malignant, primary or secondary (metastatic), in pediatric or adult populations. Relevant areas include biomarkers of risk, disease burden or treatment response, brain tumor biology, etiology, clinical research, genetics, diagnosis, imaging, drug delivery, molecular/genetic epidemiology, novel therapeutics, and risk assessment. Projects must directly relate to brain tumor research.
